- Home
- APPF vs LEGN Comparison
APPF vs LEGN Comparison
Compare APPF & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APPF
- LEGN
- Stock Information
- Founded
- APPF 2006
- LEGN 2014
- Country
- APPF United States
- LEGN United States
- Employees
- APPF N/A
- LEGN N/A
- Industry
- APPF Computer Software: Prepackaged Software
- LEGN Biotechnology: Pharmaceutical Preparations
- Sector
- APPF Technology
- LEGN Health Care
- Exchange
- APPF Nasdaq
- LEGN Nasdaq
- Market Cap
- APPF 7.9B
- LEGN 5.4B
- IPO Year
- APPF 2015
- LEGN 2020
- Fundamental
- Price
- APPF $240.60
- LEGN $39.59
- Analyst Decision
- APPF Buy
- LEGN Strong Buy
- Analyst Count
- APPF 6
- LEGN 12
- Target Price
- APPF $271.20
- LEGN $73.91
- AVG Volume (30 Days)
- APPF 268.9K
- LEGN 1.5M
- Earning Date
- APPF 07-24-2025
- LEGN 08-08-2025
- Dividend Yield
- APPF N/A
- LEGN N/A
- EPS Growth
- APPF 158.56
- LEGN N/A
- EPS
- APPF 5.36
- LEGN N/A
- Revenue
- APPF $824,474,000.00
- LEGN $728,303,000.00
- Revenue This Year
- APPF $19.35
- LEGN $65.33
- Revenue Next Year
- APPF $16.16
- LEGN $54.68
- P/E Ratio
- APPF $45.21
- LEGN N/A
- Revenue Growth
- APPF 22.73
- LEGN 112.46
- 52 Week Low
- APPF $189.01
- LEGN $27.34
- 52 Week High
- APPF $274.56
- LEGN $60.87
- Technical
- Relative Strength Index (RSI)
- APPF 60.51
- LEGN 68.12
- Support Level
- APPF $236.06
- LEGN $38.86
- Resistance Level
- APPF $248.85
- LEGN $40.78
- Average True Range (ATR)
- APPF 6.25
- LEGN 1.52
- MACD
- APPF 0.39
- LEGN 0.33
- Stochastic Oscillator
- APPF 67.23
- LEGN 85.77
About APPF AppFolio Inc.
AppFolio Inc provides cloud-based software solutions for the real estate industry. Its property management software offers property managers an end-to-end solution to their business needs. The group's products include cloud-based property management software (Appfolio Property Manager). Its solutions are AppFolio Property Manager Core, AppFolio Property Manager Plus, and AppFolio Property Manager Max. It also offers value-added services, such as screening, risk mitigation, and electronic payment services. Its markets are Single-Family, Multifamily, Student Housing, Affordable Housing, Community Associations, Commercial, and Investment Management. The business activity of the firm predominantly functions in the United States and it generates revenue in the form of subscription fees.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.